SPECTRUM PHARMACEUTICALS INC Quarterly Costs and Expenses in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Spectrum Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Costs and Expenses for the quarter ending March 31, 2023 was $20.5M, a 45.7% increase year-over-year.
  • Spectrum Pharmaceuticals Inc Costs and Expenses for the twelve months ending March 31, 2023 was $89.2M, a 30.3% decline year-over-year.
  • Spectrum Pharmaceuticals Inc annual Costs and Expenses for 2022 was $82.8M, a 43.9% decline from 2021.
  • Spectrum Pharmaceuticals Inc annual Costs and Expenses for 2021 was $148M, a 13% decline from 2020.
  • Spectrum Pharmaceuticals Inc annual Costs and Expenses for 2020 was $170M, a 20.6% increase from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $89.2M $20.5M +$6.42M +45.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $82.8M $21.8M -$15.1M -41% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $97.9M $21.6M -$11.5M -34.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $109M $25.4M -$18.7M -42.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $128M $14.1M -$19.6M -58.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $148M $36.9M -$26M -41.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $174M $33.1M -$6.48M -16.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $180M $44.1M +$7.58M +20.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $173M $33.7M +$2.9M +9.42% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $170M $62.9M +$24.5M +64% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 $145M $39.6M +$9.28M +30.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $136M $36.5M +$2.28M +6.66% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $134M $30.8M -$7.05M -18.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $141M $38.4M -$8.1M -17.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $149M $30.3M +$1.87M +6.58% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $147M $34.2M +$1.23M +3.72% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $146M $37.8M +$7.86M +26.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $138M $46.5M +$85.5M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 $52.3M $28.4M -$23M -44.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $75.3M $33M -$19.9M -37.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $95.3M $30M -$21M -41.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $116M -$39.1M -$92.8M -173% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $209M $51.4M +$2.06M +4.17% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $207M $52.9M -$3.12M -5.57% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $210M $51M +$861K +1.72% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $209M $53.8M -$1.39M -2.52% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $211M $49.4M +$4.69M +10.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $206M $56M +$11M +24.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $195M $50.1M -$10.1M -16.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $205M $55.1M +$1.66M +3.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 $203M $44.7M -$7.42M -14.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $211M $45M -$3.24M -6.71% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $214M $60.3M -$4.26M -6.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $218M $53.5M +$5.47M +11.4% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-14
Q3 2014 $213M $52.1M -$3.61M -6.48% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $217M $48.3M +$2.49M +5.44% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $214M $64.5M +$19.4M +43% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $195M $48M -$10.1M -17.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 $205M $55.7M +$9.79M +21.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $195M $45.8M -$379K -0.82% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $195M $45.1M +$8.37M +22.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $187M $58.1M +$16.2M +38.7% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $171M $45.9M +$13M +39.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 $158M $46.1M +$10.7M +30.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $147M $36.8M +$10.7M +40.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $136M $41.9M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 $33M +$9.36M +39.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $35.4M +$10.8M +44% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $26.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-27
Q3 2010 $23.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
Q2 2010 $24.6M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.